GL1X · GenesisL1 explorer

MolNFT v1 · #95512 · protein

Human glucokinase in complex with novel activator (2S)-3-cyclohexyl-2- [4-(methylsulfonyl)-2-oxopiperazin-1-yl]-N-(1,3-thiazol-2-yl) propanamide

4ISG: “Human glucokinase in complex with novel activator (2S)-3-cyclohexyl-2…”. X-ray diffraction, 3 ligands (1FY, GLC, IOD), 4 pockets (best druggability 0.69). MolNFT v1 #95512 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
4ISG
Type
protein
Length
418 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glucokinase
EC
2.7.1.2
UniProt
P35557
Ligands
1FY, GLC, IOD
Pockets
4 · best druggability 0.69

Structure

x-ray diffraction · 1 distinct chain · 50% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlucokinase (EC 2.7.1.2)protein41850% helix, 17% strandP35557

Ligands and binding sites

  • 1FY · (2S)-3-cyclohexyl-2-[4-(methylsulfonyl)-2-oxopiperazin-1-yl]-N-(1,3-thiazol-2-yl)propanamide · ligand · chains A
  • GLC · alpha-D-glucopyranose · sugar · chains A
  • IOD · Iodide ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12380.690.85251FY
21480.470.7730empty
3660.330.7523IOD
4680.310.7512empty

Compared structures

  • 4ISG · Human glucokinase in complex with novel activator… · the same entry in another collection · chain A against A, TM-score 1.00
  • P35557 · AlphaFold monomer V2.0 prediction for hexokinase-4 (P35557) · a predicted model of the same protein · chain A against A, TM-score 0.85

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.